NPI: 1215459953 · ANNANDALE, VA 22003 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/14/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/14/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 7,077 | $102K |
| 2021 | 17,385 | $225K |
| 2022 | 14,773 | $358K |
| 2023 | 6,193 | $248K |
| 2024 | 4,027 | $136K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,681 | 1,082 | $915K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,039 | 745 | $60K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 239 | 25 | $39K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 790 | 422 | $36K |
| J1756 | Injection, iron sucrose, 1 mg | 3,966 | 824 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,912 | 400 | $2K |
| A4657 | Syringe, with or without needle, each | 2,285 | 760 | $1K |
| 85041 | 700 | 456 | $1.18 | |
| 85048 | 699 | 456 | $1.00 | |
| 82728 | 227 | 155 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 45 | 26 | $0.00 |
| 83550 | 241 | 151 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 24 | 16 | $0.00 |
| 83970 | 328 | 222 | $0.00 | |
| 83540 | 279 | 180 | $0.00 |